What is the Fiscal Year for Quintiles Transnational Holdings?
Date: November 13, 2026
Quintiles Transnational Holdings's current fiscal year starts on January 1, 2025, and ends on December 31, 2025. Their current quarter is Q4, which ends on December 31, 2025.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2025
Fiscal Year End
December 31, 2025
Current Quarter
Q4
Current Quarter End
December 31, 2025
Quarterly Breakdown
Q1
Jan 1, 2025 – Mar 31, 2025
Q2
Apr 1, 2025 – Jun 30, 2025
Q3
Jul 1, 2025 – Sep 30, 2025
Q4
Oct 1, 2025 – Dec 31, 2025
Company Information
Headquarters
Durham, North Carolina, United States
Industry
Manufacturing, Pharmaceuticals
Stock Symbol
Q
Website
https://quintiles.comDescription
Quintiles Transnational Holdings Inc. is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. The Company's segments include Product Development and Integrated Healthcare Services. Its Product Development segment is a contract research organization and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. The Product Development segment consists of clinical solutions and services, and advisory services. The Integrated Healthcare Services segment includes commercial pharmaceutical sales and service organizations, and provides services, including commercial services, such as contract pharmaceutical sales forces, and healthcare business services for the healthcare sector, such as phase research, market access and consulting, health information analytics and technology consulting, and other healthcare solutions.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Quintiles Transnational Holdings and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.